Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Neovascular (Wet) Age-Related Macular Degeneration
Clinical Trial
NCT04126317Last updated: 1/8/2026
REGN
Regeneron Pharmaceuticals, Inc.